Coverage
-
October 26, 2016
A California federal judge on Wednesday granted $23.8 million in attorneys' fees to Labaton Sucharow LLP and others serving as class counsel to investors who reached a $95 million settlement with Amgen Inc. over the company's alleged misstatements about two of its anti-anemia drugs.
2 other articles on this case.
View all »